BioVaxys Technology (TSE:BIOV) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BioVaxys Technology Corp. and SpayVac for Wildlife, Inc. have announced the completion of a new research and production facility in Madison, Wisconsin for SpayVac’s long-lasting, single-dose contraceptive vaccines for animals. The facility will support the development of vaccines for wildlife and agricultural animals, with plans to commercialize and generate royalty revenue for BioVaxys from its licensed technology.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
